Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra.
Chu Y, Kompoliti K, Cochran EJ, Mufson EJ, Kordower JH
Nurr1, a key protein for dopamine neuron function, decreases with age in the human brain's dopamine-producing region. This drop in Nurr1 matches the decline in dopamine markers, suggesting aging reduces dopamine neuron health by turning down Nurr1, not by killing neurons. The findings highlight Nurr1 as a potential target for protecting dopamine neurons in aging and neurodegenerative conditions.
- Nurr1 levels drop in dopamine neurons with age
- Lower Nurr1 matches reduced dopamine markers
- Neuron loss is not due to cell death but reduced function
- Nurr1 decline may drive age-related dopamine decline
- Targeting Nurr1 could protect dopamine neurons
Defining requirements for heterodimerization between the retinoid X receptor and the orphan nuclear receptor Nurr1.
Aarnisalo P, Kim CH, Lee JW, Perlmann T
Nurr1, a key protein for brain development, can work alone or team up with RXR to control genes. Specific changes in Nurr1's structure can block this teamwork without harming its normal function, which helps scientists study how each form works. This discovery could guide future treatments for NR4A2-related disorders by targeting Nurr1's dimerization.
- Nurr1 works as a monomer or with RXR to regulate genes
- Certain mutations in Nurr1 block RXR pairing without affecting normal function
- RXR binding reduces Nurr1's natural activity
- The dimer interface is unique and differs from other nuclear receptor pairs
- This helps separate Nurr1's roles for potential therapies
Requirements for heterodimerization between the orphan nuclear receptor Nurr1 and retinoid X receptors.
Sacchetti P, Dwornik H, Formstecher P, Rachez C, Lefebvre P
Nurr1 activates gene transcription on its own without needing to pair with RXR, but when it does form a pair, it only works with specific RXR types and only when bound to DNA. The activity of these pairs depends on having at least three Nurr1 binding sites together, which limits how and where Nurr1 can respond to retinoids.
- Nurr1 works alone to turn on genes
- Only certain RXR types can pair with Nurr1
- The pair must be bound to DNA to function
- Three Nurr1 sites are needed for retinoid response
- This restricts retinoid effects to specific gene locations
Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.
Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F, Arzt E
CRH and cAMP stimulate the activity of Nur77 and Nurr1 proteins in corticotroph cells through multiple signaling pathways, including PKA, calcium/calmodulin kinase II, and MAPK. These pathways are essential for turning on POMC gene expression, which controls stress hormone production.
- CRH/cAMP activates Nur77 and Nurr1 in stress hormone cells
- PKA, calcium, and MAPK pathways all contribute to Nur protein activity
- MAPK boosts Nur77 function by phosphorylating it
- Blocking MAPK stops Nur from turning on genes, even if mRNA is made
- These pathways are critical for stress hormone production
Dopaminergic differentiation of the Nurr1-expressing immortalized mesencephalic cell line CSM14.1 in vitro.
Haas SJ, Wree A
The CSM14.1 cell line, which expresses the Nurr1 protein, can be turned into dopamine-producing brain cells in the lab under specific conditions. This model helps study how dopaminergic neurons develop and may inform future therapies for Parkinson’s disease.
- CSM14.1 cells express Nurr1 and become dopamine neurons in lab conditions
- Differentiation involves clear changes in protein markers over time
- Results match what happens in developing rat brains
- Provides a tool to study Nurr1-related neuron development
- May help develop cell-based treatments for dopamine-related disorders
Nurr1 affects pRL-TK but not phRG-B internal control plasmid in genetic reporter system.
Matuszyk J, Ziolo E, Cebrat M, Kochel I, Strzadala L
Nurr1, a protein linked to NR4A2-related syndrome, can falsely increase results in a common lab test by boosting the activity of a control plasmid (pRL-TK), leading to inaccurate conclusions. Using a different control plasmid (phRG-B) avoids this issue and gives more reliable data.
- Nurr1 falsely boosts a standard control plasmid
- This can mislead results in gene activity tests
- Use phRG-B instead of pRL-TK for accurate results
- Nurr1 does not affect Fas Ligand promoter activity
The activation function-1 domain of Nur77/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment.
Wansa KD, Harris JM, Muscat GE
The AF-1 domain in Nur77/NR4A1 is essential for turning on gene expression without hormones, recruiting key coactivators, and working with other parts of the protein to control gene activity in a cell-specific way.
- AF-1 domain drives gene activation without hormones
- AF-1 recruits coactivators like SRC-2 and p300
- AF-1 interacts with both the protein's own LBD and other receptors
- Nur77's LBD cannot bind coactivators directly
- AF-1 function is critical for transcriptional control
Corticotropin-releasing hormone signaling in synovial tissue vascular endothelium is mediated through the cAMP/CREB pathway.
McEvoy AN, Bresnihan B, Fitzgerald O, Murphy EP
Corticotropin-releasing hormone (CRH) activates a signaling pathway in blood vessel cells within inflamed joints, leading to changes that worsen arthritis. This process involves the cAMP/CREB pathway and increases production of NURR1, a protein linked to NR4A2-related disorders.
- CRH triggers inflammation in joint blood vessels via cAMP/CREB
- NURR1, related to NR4A2, is activated in the same cells
- This pathway may worsen joint damage in arthritis
- CRH effects mimic those of cAMP activation
- Suggests potential for targeting this pathway in treatment
Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers.
Bannon MJ, Pruetz B, Manning-Bog AB, Whitty CJ, Michelhaugh SK, Sacchetti P, Granneman JG, Mash DC, Schmidt CJ
People who abused cocaine have lower levels of the NURR1 protein in their dopamine brain cells, which also leads to reduced levels of the dopamine transporter, a key protein involved in brain chemistry. This suggests NURR1 plays a critical role in regulating brain function in response to cocaine and may be involved in long-term changes seen in addiction.
- NURR1 levels are low in dopamine neurons of cocaine abusers
- Lower NURR1 links to reduced dopamine transporter levels
- NURR1 helps control brain responses to repeated cocaine use
- This finding may explain long-term brain changes in addiction
Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease.
Xu PY, Liang R, Jankovic J, Hunter C, Zeng YX, Ashizawa T, Lai D, Le WD
A specific genetic variant in the Nurr1 gene, found in both familial and sporadic Parkinson's disease patients, is linked to a higher risk of developing the disease. This variant does not change the protein but may affect gene function and is more common in people with Parkinson's than in healthy individuals.
- A specific Nurr1 gene variant is more common in Parkinson's patients
- The variant is in an intron, not the protein-coding part
- It increases Parkinson's risk but doesn't change typical symptoms
- Found in both familial and sporadic cases
- May affect gene regulation, not protein structure
Generation of tyrosine hydroxylase-immunoreactive neurons in ventral mesencephalic tissue of Nurr1 deficient mice.
Tornqvist N, Hermanson E, Perlmann T, Stromberg I
Nurr1-deficient mouse brain tissue can still produce neurons that make tyrosine hydroxylase (TH), the key enzyme for dopamine production, especially when grown with healthy tissue or in certain conditions. This suggests that Nurr1 is not absolutely required for TH expression in lab-grown brain cells, though it plays a role in proper neuron organization and function.
- TH-positive neurons form in Nurr1-deficient brain tissue in lab cultures
- Nurr1 is not essential for TH gene expression in vitro
- Healthy tissue can support TH neuron development even without Nurr1
- Proper nerve fiber organization still requires Nurr1
- Growth factors did not restore TH in Nurr1-deficient cultures
Mutation analysis of the retinoid X receptor beta, nuclear-related receptor 1, and peroxisome proliferator-activated receptor alpha genes in schizophrenia and alcohol dependence: possible haplotype association of nuclear-related receptor 1 gene to alcohol dependence.
Ishiguro H, Okubo Y, Ohtsuki T, Yamakawa-Kobayashi K, Arinami T
Variants in the NR4A2 gene, which codes for the NURR1 protein, are linked to alcohol dependence in a Japanese population, suggesting that this gene may play a role in the genetic risk for substance use disorders. While no direct mutations were found, a specific combination of genetic markers (haplotype) in NR4A2 was significantly associated with alcohol dependence.
- NR4A2 gene haplotype linked to alcohol dependence
- No direct mutations found in NR4A2
- NURR1 is involved in brain development and dopamine regulation
- Findings suggest NR4A2 as a potential risk factor for substance use
- May inform future research on neurodevelopmental and psychiatric conditions
Mutation analysis of the human NR4A2 gene, an essential gene for midbrain dopaminergic neurogenesis, in schizophrenic patients.
Chen YH, Tsai MT, Shaw CK, Chen CH
A rare mutation in the NR4A2 gene, called c.-469delG, was found in two unrelated individuals with schizophrenia but not in healthy controls, suggesting this gene may contribute to the development of schizophrenia. This gene is critical for the formation of dopamine-producing brain cells, which are involved in mental health disorders.
- A rare NR4A2 mutation was found in two schizophrenia patients
- The mutation was not present in healthy controls
- NR4A2 is essential for dopamine neuron development
- This suggests a possible role in schizophrenia pathogenesis
Orphan nuclear receptor Nurr1 is essential for Ret expression in midbrain dopamine neurons and in the brain stem.
Wallén A A, Castro DS, Zetterström RH, Karlén M, Olson L, Ericson J, Perlmann T
Nurr1 controls the expression of Ret in dopamine neurons and brain stem cells, which is critical for proper development and function of these neurons. This relationship explains key aspects of NR4A2-related syndrome, including impaired neuron migration and connectivity.
- Nurr1 regulates Ret expression in dopamine neurons
- Ret loss disrupts neuron development and connectivity
- Nurr1 is essential for brain stem neuron organization
- This pathway affects both brain development and function
- Findings may inform future therapies for NR4A2-related disorders
Retinoic acid prevents experimental Cushing syndrome.
Páez-Pereda M, Kovalovsky D, Hopfner U, Theodoropoulou M, Pagotto U, Uhl E, Losa M, Stalla J, Grübler Y, Missale C, Arzt E, Stalla GK
Retinoic acid reduces ACTH production and tumor growth in models of Cushing syndrome by blocking key transcription factors, including Nurr1, and shows promise as a treatment for hormone-secreting tumors. It also lowers corticosterone levels and slows cell proliferation in adrenal cells.
- Retinoic acid blocks Nurr1 and other transcription factors in ACTH tumors
- It reduces ACTH and corticosterone production in tumor and adrenal cells
- Retinoic acid stops tumor growth and triggers cell death in lab models
- Effectiveness depends on COUP-TFI levels, which are missing in tumors
- Results were confirmed in live animal models of Cushing syndrome
Silencing mediator of retinoid and thyroid hormone receptors and activating signal cointegrator-2 as transcriptional coregulators of the orphan nuclear receptor Nur77.
Sohn YC, Kwak E, Na Y, Lee JW, Lee SK
SMRT acts as a corepressor that dampens Nur77 activity, while ASC-2 enhances it; SMRT may compete with an unknown adaptor protein for binding to Nur77, suggesting a dynamic regulatory mechanism that could be targeted therapeutically.
- SMRT represses Nur77 activity by binding to it
- ASC-2 boosts Nur77 function but doesn’t bind directly
- SMRT’s repression is not reversed by HDAC inhibitors
- An unknown adaptor may link ASC-2 to Nur77
- This competition could be a target for therapy
Induction of cell cycle arrest and morphological differentiation by Nurr1 and retinoids in dopamine MN9D cells.
Castro DS, Hermanson E, Joseph B, Wallén A, Aarnisalo P, Heller A, Perlmann T
Nurr1 helps dopamine-producing cells stop dividing and mature into fully developed cells, a process that may be relevant to treating NR4A2-related disorders. Retinoids and related proteins can also drive this maturation independently of Nurr1.
- Nurr1 stops cell division and promotes maturation in dopamine cells
- This effect works through DNA binding, not through partnering with retinoid receptors
- Retinoids can trigger similar maturation without Nurr1
- Other related proteins (NGFI-B, Nor1) have similar effects
- These findings may inform therapies for NR4A2-related conditions
A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease.
Carvey PM, Ling ZD, Sortwell CE, Pitzer MR, McGuire SO, Storch A, Collier TJ
A specific line of brain progenitor cells can be grown in the lab and turned into dopamine-producing neurons using certain immune system proteins. These lab-made neurons survive transplantation and improve movement problems in a rat model of Parkinson's disease, showing promise for future cell therapies.
- Lab-grown brain cells become dopamine neurons using immune proteins
- Cells survive and improve symptoms in Parkinson's rats
- Results are stable after freezing and multiple cell divisions
- Potential for future cell transplants in Parkinson's disease
- Nurr1 expression suggests relevance to NR4A2-related biology
Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors.
Rolletschek A, Chang H, Guan K, Czyz J, Meyer M, Wobus AM
Survival-promoting factors boost the development and function of dopamine-producing neurons from stem cells, increasing their numbers, dopamine production, and resistance to cell death. This suggests potential strategies for improving neuron survival in NR4A2-related disorders.
- Survival factors increase dopamine neuron production
- Neurons show higher dopamine levels and better survival
- Nurr1 and tyrosine hydroxylase are upregulated
- Anti-apoptotic gene bcl-2 is enhanced
- Findings may inform cell-based therapies
In vitro regulated expression of tyrosine hydroxylase in ventral midbrain neurons from Nurr1-null mouse pups.
Eells JB, Rives JE, Yeung SK, Nikodem VM
Dopamine-producing neurons from mice without the Nurr1 gene can still be triggered to make tyrosine hydroxylase (TH), a key enzyme for dopamine production, when treated with forskolin and other factors in lab dishes. This shows that these neurons remain capable of developing into dopamine-producing cells even without Nurr1, suggesting potential for reactivation of dopamine pathways.
- Neurons without Nurr1 can still make TH in lab conditions
- Forskolin and other factors boost TH production
- Undifferentiated neurons remain responsive to stimulation
- Nurr1 loss doesn't permanently block dopamine development
- Findings suggest possible ways to reactivate dopamine pathways
Physiological patterns of electrical stimulation can induce neuronal gene expression by activating N-type calcium channels.
Brosenitsch TA, Katz DM
N-type calcium channels, not L-type channels, are essential for turning on specific neuronal genes in response to natural patterns of electrical activity, which may be relevant to how brain cells adapt and function in conditions like NR4A2-related syndrome.
- N-type calcium channels drive gene expression during normal brain activity patterns
- L-type channels are not needed for gene activation by natural stimulation
- Blocking N-type channels stops gene activation, even if L-type channels are intact
- Different signaling pathways (PKA/PKC vs. MAPK) control gene expression based on stimulation type
- This challenges old assumptions about how neurons respond to activity at the genetic level
Pitx3 activates mouse tyrosine hydroxylase promoter via a high-affinity binding site.
Lebel M, Gauthier Y, Moreau A, Drouin J
Pitx3 directly activates the gene that makes tyrosine hydroxylase, the key enzyme for dopamine production, in mouse brain cells. This activation depends on a specific DNA site and may involve other factors that vary by cell type.
- Pitx3 turns on the tyrosine hydroxylase gene in dopamine neurons
- A single DNA site is critical for Pitx3 to activate this gene
- Pitx3's effect depends on the cell type, suggesting other regulators are involved
- Nurr1, another important gene for dopamine neurons, does not affect this gene's activity
Involvement of the nuclear orphan receptor NURR1 in the regulation of corticotropin-releasing hormone expression and actions in human inflammatory arthritis.
Murphy EP, McEvoy A, Conneely OM, Bresnihan B, FitzGerald O
NURR1, a transcription factor linked to NR4A2, plays a key role in driving inflammation in arthritis by regulating CRH expression in joint tissue. Inflammatory signals boost NURR1, which in turn amplifies joint inflammation, and this process can be suppressed by glucocorticoids.
- NURR1 is highly active in inflamed joint tissue in arthritis
- Inflammation increases NURR1, which boosts CRH and worsens joint damage
- Glucocorticoids reduce NURR1 levels and may help control inflammation
- NURR1 is a central player in arthritis-related inflammation
Distribution of the orphan nuclear receptor Nurr1 in medaka (Oryzias latipes): cues to the definition of homologous cell groups in the vertebrate brain.
Kapsimali M, Bourrat F, Vernier P
Nurr1, a gene linked to brain development and dopamine function in humans, is present in similar brain regions in medaka fish, suggesting its role in nervous system development has been preserved across vertebrates for hundreds of millions of years.
- Nurr1 is found in brain areas also seen in mammals, including dopamine-related regions
- The fish brain shows Nurr1 in locations matching human hypothalamic and brainstem nuclei
- Nurr1 and dopamine-making enzyme genes coexist in the same cells, just like in humans
- This supports the idea that Nurr1's role in brain development is ancient and shared across species
- Findings help identify which brain cells may be affected in NR4A2-related disorders
Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism.
Sacchetti P, Mitchell TR, Granneman JG, Bannon MJ
Nurr1 directly boosts the activity of the human dopamine transporter gene, which is crucial for dopamine neuron function, using a previously unknown mechanism that does not rely on typical DNA binding sites. This finding highlights Nurr1's role in maintaining dopamine neuron identity beyond development.
- Nurr1 increases dopamine transporter gene activity
- Mechanism is new and does not use standard DNA binding sites
- Nurr1's role extends beyond neuron development
- Relevance to dopamine neuron maintenance in humans
- Potential implications for NR4A2-related syndrome therapies
Parathyroid hormone induces expression of the nuclear orphan receptor Nurr1 in bone cells.
Tetradis S, Bezouglaia O, Tsingotjidou A
Parathyroid hormone (PTH) triggers the production of Nurr1, a key transcription factor, in bone cells through the cAMP/PKA signaling pathway. This suggests a direct link between PTH and Nurr1, which may influence how bone cells respond to hormones and could inform future treatments for bone-related conditions.
- PTH rapidly increases Nurr1 levels in bone cells
- Nurr1 is activated via the cAMP/PKA pathway
- Nurr1 may connect PTH and hormone signaling in bone
- This interaction could affect bone development and repair
Expression of Nuclear Orphan Receptors Ngfi-B/Tr3, Nurr1 And Nor-1 after Global Brain Ischemia in Rat.
Schmidt-Kastner R, Zetterstr M R, Hakim AM
This study examines how three nuclear receptors—Nurr1, Nor-1, and Ngfi-B—are affected in rat brains after a global ischemia event, which mimics oxygen deprivation seen in conditions like cardiac arrest. The findings show that Nurr1 expression increases significantly after ischemia, suggesting a protective or repair role in brain injury.
- Nurr1 levels rise after brain oxygen deprivation in rats
- Nurr1 may help protect or repair brain tissue
- Other related receptors also change after injury
- Findings suggest Nurr1 could be a therapeutic target
Nigrostriatal innervation is preserved in Nurr1-null mice, although dopaminergic neuron precursors are arrested from terminal differentiation.
Witta J, Baffi JS, Palkovits M, Mezey E, Castillo SO, Nikodem VM
Nurr1 is essential for the final maturation of dopamine-producing neurons in the brain, but not for their early development, survival, or connection to the striatum. In mice without Nurr1, dopamine neurons form and send axons to the right places but fail to produce dopamine, suggesting that boosting Nurr1 activity could help treat Parkinson's disease.
- Nurr1 is needed for dopamine neuron maturation, not early development
- Dopamine neurons survive and connect to the striatum without Nurr1
- Neurons in Nurr1-null mice lack dopamine-making enzymes
- Activating Nurr1 may help treat Parkinson's disease
- Nigrostriatal pathways remain intact despite lack of dopamine
NURR1 mutations in cases of schizophrenia and manic-depressive disorder.
Buervenich S, Carmine A, Arvidsson M, Xiang F, Zhang Z, Sydow O, Jönsson EG, Sedvall GC, Leonard S, Ross RG, Freedman R, Chowdari KV, Nimgaonkar VL, Perlmann T, Anvret M, Olson L
Mutations in the NURR1 gene are linked to schizophrenia and manic-depressive disorder, reducing the gene's activity by 30-40% in affected individuals. These mutations were not found in people with Parkinson's disease or in healthy controls, suggesting a specific role in certain psychiatric conditions.
- NURR1 mutations found in schizophrenia and bipolar disorder
- Mutations reduce NURR1 gene activity by 30-40%
- No mutations found in Parkinson’s patients or healthy controls
- NURR1 is critical for dopamine neuron development
- Suggests NURR1 dysfunction may contribute to psychiatric illness
Stress induces zinc finger immediate early genes in the rat adrenal gland.
Honkaniemi J, Zhang JS, Longo FM, Sharp FR
Stress rapidly activates specific genes in the rat adrenal gland, which control hormone release. Different genes turn on at different times and places, suggesting they play unique roles in the body's stress response.
- Stress triggers immediate-early genes in adrenal glands
- NGFI-B and Nurr1 activate quickly in hormone-producing zones
- Gene activation patterns vary by location and timing
- These genes likely regulate stress-related hormone release
- Findings may inform how stress affects NR4A2-related conditions
Hippocampal expression of the orphan nuclear receptor gene hzf-3/nurr1 during spatial discrimination learning.
Peña de Ortiz S, Maldonado-Vlaar CS, Carrasquillo Y
The gene NR4A2 (also called NURR1) increases in the hippocampus during learning, suggesting it plays a key role in forming long-term spatial memories. This finding links NR4A2 activity directly to memory processes in the brain.
- NR4A2 levels rise in the hippocampus during learning
- Increased NR4A2 is linked to long-term memory formation
- This effect occurs in brain regions critical for memory
- NR4A2 is activated during spatial task acquisition
- Findings suggest NR4A2 is involved in memory storage
Selective increase of Nurr1 mRNA expression in mesencephalic dopaminergic neurons of D2 dopamine receptor-deficient mice.
Tseng KY, Roubert C, Do L, Rubinstein M, Kelly MA, Grandy DK, Low MJ, Gershanik OS, Murer MG, Giros B, Raisman-Vozari R
In mice without D2 dopamine receptors, Nurr1 levels rise specifically in brain regions that produce dopamine, suggesting dopamine signaling normally keeps Nurr1 in check. This finding hints that boosting dopamine activity might help regulate Nurr1, which is crucial for dopamine neuron survival.
- Nurr1 increases in dopamine neurons when D2 receptors are missing
- This effect is only seen in dopamine-producing brain areas
- Dopamine may normally suppress Nurr1 via D2 receptors
- Nurr1 is vital for dopamine neuron development and survival
- Suggests dopamine signaling fine-tunes Nurr1 levels
Identification of a potential nurr1 response element that activates the tyrosine hydroxylase gene promoter in cultured cells.
Iwawaki T, Kohno K, Kobayashi K
Nurr1 directly activates the tyrosine hydroxylase (TH) gene, which is essential for dopamine production, by binding to a specific DNA sequence in the TH gene promoter. This interaction helps control dopamine neuron development and function, offering insight into how NR4A2 mutations might disrupt brain chemistry in affected children.
- Nurr1 activates the TH gene, critical for dopamine production
- A specific DNA site (TH-NBRE1) mediates this activation
- This mechanism is key for dopamine neuron development
- NR4A2 mutations may disrupt this process in patients
- Findings support potential therapeutic targeting of Nurr1 pathways
The aging process: where are the drug opportunities?
Smith RG
Nurr1, a protein linked to Parkinson's disease, is a promising drug target for treating neurodegenerative conditions, including those related to NR4A2 dysfunction. Propargylamines may protect neurons from oxidative damage, suggesting potential therapeutic strategies.
- Nurr1 is a key target for Parkinson's disease treatments
- Propargylamines may reduce neuronal oxidative damage
- NR4A2 and Nurr1 are closely related in brain function
- These findings may inform therapies for NR4A2-related syndromes
A response element for the homeodomain transcription factor Ptx3 in the tyrosine hydroxylase gene promoter.
Cazorla P, Smidt MP, O'Malley KL, Burbach JP
Ptx3 is a transcription factor that boosts the activity of the tyrosine hydroxylase (TH) gene in dopamine-producing brain cells, especially when working with Nurr1, a key protein linked to NR4A2-related disorders. This interaction helps control dopamine production, which is central to the function of neurons affected in NR4A2 syndrome.
- Ptx3 enhances TH gene activity in dopamine neurons
- Ptx3 works with Nurr1 to boost TH expression
- Effect depends on cell type, showing specificity
- Ptx3 binding site is near the main TH regulatory region
- Findings may inform therapies targeting dopamine pathways
A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b.
Smidt MP, Asbreuk CH, Cox JJ, Chen H, Johnson RL, Burbach JP
Lmx1b is essential for the proper development of midbrain dopamine neurons, even though dopamine production can still begin without it. Without Lmx1b, these neurons fail to mature and eventually die, showing that multiple genetic pathways control different aspects of neuron development.
- Lmx1b is critical for midbrain dopamine neuron maturation
- Dopamine production starts without Lmx1b, but neurons don’t survive
- Two separate genetic pathways control dopamine neuron development
- Lmx1b helps turn on genes needed for neuron identity and survival